{"id":"W7116870583","doi":"10.1016/s1470-2045(25)00614-x","title":"Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Brain Tumour Charity; Cancer Research UK; Cancer Australia; American College of Radiology; KWF Kankerbestrijding; NRG Oncology; European Organisation for Research and Treatment of Cancer; MSD","keywords":"Temozolomide; Adjuvant; Glioblastoma; Clinical trial; Phases of clinical research; Anaplastic astrocytoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001690455,0.001467508,0.002709072,0.0003663955,0.0003465908,0.001081531,0.000847504,0.001244343,0.005027338],"category_scores_gemma":[0.001544868,0.0005784461,0.001845118,0.0004663308,0.001293108,0.001262451,0.0004593249,0.003149081,0.0008630275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001333533,"about_ca_system_score_gemma":0.001631789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003077092,"about_ca_topic_score_gemma":0.01088783,"domain_scores_codex":[0.9993308,0.0003590189,0.00002768813,0.0001275816,0.0000464288,0.0001085922],"domain_scores_gemma":[0.9991098,0.0002490763,0.0001645655,0.00008422691,0.00004167117,0.000350556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9728981,0.003809551,0.0009001393,0.0005399008,0.001119851,0.0000340245,0.00008843792,0.0007349757,0.002465535,0.0001570383,0.0008422793,0.01641006],"study_design_scores_gemma":[0.8839354,0.1089346,0.003786498,0.00004940095,0.0008214805,0.00006418793,0.00005686904,0.0005714251,0.0004558687,0.0003062025,0.0009972863,0.00002078758],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912394,0.003754547,0.0004112804,0.0003815586,0.0002740989,0.001125581,0.0009343681,0.00006470966,0.001814407],"genre_scores_gemma":[0.9899744,0.002572671,0.0009395203,0.0004465844,0.0001725632,0.001304192,0.001584694,0.0000297574,0.002975625],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005027338,"threshold_uncertainty_score":0.01681805,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.219077934047368,"score_gpt":0.4929216665418885,"score_spread":0.2738437324945205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}